Don’t miss the latest developments in business and finance.

Sanofi receives consideration of Rs 587.64 cr for sale of its nutraceuticals biz

Image
Capital Market
Last Updated : Sep 30 2021 | 11:31 AM IST

On 29 September 2021

Sanofi India has completed the transaction for slump sale and transfer of the company's Nutraceuticals business, on a going concern basis to Universal Nutriscience on 29 September 2021.

After the working capital adjustment on the closing date, the total consideration for the transaction has been calculated at Rs. 587.64 crore. The company has received the final consideration of Rs. 587.64 crore on the closing date.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Sep 30 2021 | 11:16 AM IST

Next Story